botensilimab,balstilimab
agenus
we re in barcelona, spain, and our team is thrilled to be sharing our presentation, botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-pd-1) for metastatic heavily pretreated microsatellite stable colorectal cancer, with #esmogi
Our goal is to treat cancers with novel combinations using our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines & adjuvants